CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product, DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 milligrams per milliliter (mg/mL), and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). The Company is also commercializing a portfolio of anti-infective products including MINOCIN, REZZAYO, VABOMERE, ORBACTIV, BAXDELA, and KIMYRSA, as well as TOPROL-XL.
Back to dashboard
Company Information
About this company
Key people
Joseph Todisco
Chairman of the Board, Chief Executive Officer
Steven W. Lefkowitz
Independent Director
Susan Blum
Chief Financial Officer, Executive Vice President
Elizabeth Hurlburt
Chief Operating Officer, Executive Vice President
Beth Zelnick Kaufman
Executive Vice President, Chief Legal and Compliance Officer, Corporate Secretary
Michael Seckler
Executive Vice President and Chief Commercial Officer
Myron M. Kaplan
Lead Independent Director
Janet M. Dillione
Independent Director
Gregory Scott Duncan
Independent Director
Alan William Dunton
Independent Director
Click to see more
Key facts
- Shares in issue77.94m
- EPICCRMD
- ISINUS21900C3088
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap$637.58m
- Employees191
- ExchangeNASDAQ
- IndexTR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.